TD Cowen analyst Gary Taylor lowered the firm’s price target on Alignment Healthcare to $8 from $10 and keeps an Outperform rating on the shares. The fir said the 3Q was inline with their model so they are maintaining their forward EBITDA estimates as they slightly push 2024 MA enrollment growth to 20% from 19%..
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ALHC:
- Alignment Healthcare Reports Third Quarter 2023 Results; Exceeds Guidance Across All Key Financial Metrics
- Alignment Healthcare sees FY23 revenue $1.78B-$1.8B, consensus $1.78B
- Alignment Healthcare sees Q4 revenue $422M-$442M, consensus $434.86M
- Alignment Healthcare reports Q3 EPS (19c), consensus (18c)
- Alignment Healthcare downgraded to Neutral from Buy at BofA